天弘国证生物医药ETF(159859)资产负债表
|
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
资产 |
银行存款 |
- |
- |
- |
- |
结算备付金 |
3,041,933.53 |
1,886,765.85 |
1,318,660.97 |
1,194,686.87 |
存出保证金 |
1,448,789.38 |
1,508,849.03 |
845,941.36 |
1,943,719.05 |
交易性金融资产 |
3,259,624,176.29 |
3,163,681,905.65 |
2,601,806,463.20 |
3,022,119,241.83 |
其中:股票投资 |
3,259,624,176.29 |
3,163,681,905.65 |
2,601,806,463.20 |
3,022,119,241.83 |
债券投资 |
- |
- |
- |
- |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
13,415,532.94 |
5,304,513.58 |
5,242,879.65 |
362,153.24 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
466,701.80 |
- |
应收申购款 |
- |
- |
- |
- |
其他资产 |
75,616.24 |
- |
125,211.83 |
92,813.98 |
资产总计 |
3,288,022,830.04 |
3,195,921,320.16 |
2,620,057,813.62 |
3,033,959,497.42 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
19,637,975.29 |
11,668,286.69 |
6,621,776.51 |
3,985,125.68 |
应付赎回款 |
- |
- |
- |
- |
应付管理人报酬 |
1,319,667.77 |
1,366,969.67 |
1,082,075.35 |
1,261,229.51 |
应付托管费 |
263,933.55 |
273,393.95 |
216,415.07 |
252,245.91 |
应付销售服务费 |
- |
- |
- |
- |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
- |
- |
33,212.37 |
7,803.33 |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
452,184.46 |
472,632.80 |
387,651.75 |
496,872.94 |
负债合计 |
21,673,761.07 |
13,781,283.11 |
8,341,131.05 |
6,003,277.37 |
所有者权益 |
实收基金 |
8,852,840,054.00 |
8,816,840,054.00 |
7,738,640,054.00 |
6,408,440,054.00 |
未分配利润 |
-5,586,490,985.03 |
-5,634,700,016.95 |
-5,126,923,371.43 |
-3,380,483,833.95 |
所有者权益合计 |
3,266,349,068.97 |
3,182,140,037.05 |
2,611,716,682.57 |
3,027,956,220.05 |
负债及所有者权益总计 |
3,288,022,830.04 |
3,195,921,320.16 |
2,620,057,813.62 |
3,033,959,497.42 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年